Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126909912 | 12690991 | 2 | F | 20160720 | 20160830 | 20160826 | 20160901 | EXP | PHHO2016NL012388 | NOVARTIS | 76.00 | YR | M | Y | 68.80000 | KG | 20160901 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126909912 | 12690991 | 1 | PS | CERTICAN | EVEROLIMUS | 1 | Oral | 2.5 MG, BID | 1685 | MG | 21560 | 2.5 | MG | TABLET | BID | ||||
| 126909912 | 12690991 | 2 | SS | PROGRAFT | TACROLIMUS | 1 | Unknown | 3 MG, BID | 2028 | MG | 0 | 3 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126909912 | 12690991 | 1 | Renal transplant |
| 126909912 | 12690991 | 2 | Renal transplant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126909912 | 12690991 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126909912 | 12690991 | C-reactive protein increased | |
| 126909912 | 12690991 | Pubic pain | |
| 126909912 | 12690991 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126909912 | 12690991 | 1 | 20150819 | 20160817 | 0 | |
| 126909912 | 12690991 | 2 | 20150818 | 20160817 | 0 |